23 January 2018
News and Views
Links and Services
February's issue of the Alimentary Pharmacology & Therapeutics investigates the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis.
Chronic hepatitis B (CHB) may lead to cirrhosis, hepatocellular carcinoma and premature death. El
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors